Dr Daniel Kelly

Dr. Daniel Kelly is a Biochemist and mechanistic biologist specialising in the role of testosterone in health and disease. He has 18 years of experience investigating the effects of testosterone on metabolic and cardiovascular risk factors using cell culture systems, pre-clinical models and clinical trials of testosterone replacement establishing his expertise as a key opinion leader in the field of Andrology. He has built up collaborative relationships with the global clinical experts in androgen therapy and uses this to direct his translational research on key clinical issues regarding testosterone in Men’s health.

Dr. Kelly has authored numerous scientific papers, abstracts and book chapters dealing with testosterone and many aspects of men’s health including diabetes, sexual function, kidney and liver disease, Covid-19, cardiovascular disease, quality of life and the science underpins this. He has been a presenter at many international endocrine meetings winning awards and fostering research collaborations across the globe. Dr Kelly also enjoys communicating his research to the public with several article in the Conversation, Men’s Fitness magazine, IFL Science and BBC science focus.

Dr. Kelly received his undergraduate Human Biology degree from Aston University, UK before undertaking a PhD at Sheffield Hallam University where his testosterone research began. After several years as a postdoctoral researcher at the University of Sheffield he returned to Sheffield Hallam as a lecturer in Biochemistry where his research informs his teaching to inspire the next generation of scientists. He maintains strong links with the University of Sheffield where he is a long-standing honorary senior lecturer.

He is an active member of the Society for Endocrinology, Endocrine Society, and the Androgen society and he reviews manuscripts and grant applications on testosterone research for numerous high-impact journals and funding bodies such as Diabetes UK and the British Heart Foundation.